亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

医学 耐受性 免疫原性 不利影响 接种疫苗 病毒学 内科学 免疫学 抗体 安慰剂 随机对照试验 血清转化 重组DNA
作者
Fengcai Zhu,Yuhua Li,Xuhua Guan,Lihua Hou,Wenjuan Wang,Jingxin Li,Shipo Wu,Busen Wang,Xiaolong Yang,Lei Wang,Siyue Jia,Hu-Dachuan Jiang,Ling Wang,Tao Jiang,Yi Hu,Jin-Bo Gou,Shabei Xu,Hong Shang,Xuewen Wang,Wei Wang,Wei Chen
出处
期刊:The Lancet [Elsevier BV]
卷期号:395 (10240): 1845-1854 被引量:956
标识
DOI:10.1016/s0140-6736(20)31208-3
摘要

A vaccine to protect against COVID-19 is urgently needed. We aimed to assess the safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine expressing the spike glycoprotein of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain.We did a dose-escalation, single-centre, open-label, non-randomised, phase 1 trial of an Ad5 vectored COVID-19 vaccine in Wuhan, China. Healthy adults aged between 18 and 60 years were sequentially enrolled and allocated to one of three dose groups (5 × 1010, 1 × 1011, and 1·5 × 1011 viral particles) to receive an intramuscular injection of vaccine. The primary outcome was adverse events in the 7 days post-vaccination. Safety was assessed over 28 days post-vaccination. Specific antibodies were measured with ELISA, and the neutralising antibody responses induced by vaccination were detected with SARS-CoV-2 virus neutralisation and pseudovirus neutralisation tests. T-cell responses were assessed by enzyme-linked immunospot and flow-cytometry assays. This study is registered with ClinicalTrials.gov, NCT04313127.Between March 16 and March 27, 2020, we screened 195 individuals for eligibility. Of them, 108 participants (51% male, 49% female; mean age 36·3 years) were recruited and received the low dose (n=36), middle dose (n=36), or high dose (n=36) of the vaccine. All enrolled participants were included in the analysis. At least one adverse reaction within the first 7 days after the vaccination was reported in 30 (83%) participants in the low dose group, 30 (83%) participants in the middle dose group, and 27 (75%) participants in the high dose group. The most common injection site adverse reaction was pain, which was reported in 58 (54%) vaccine recipients, and the most commonly reported systematic adverse reactions were fever (50 [46%]), fatigue (47 [44%]), headache (42 [39%]), and muscle pain (18 [17%]. Most adverse reactions that were reported in all dose groups were mild or moderate in severity. No serious adverse event was noted within 28 days post-vaccination. ELISA antibodies and neutralising antibodies increased significantly at day 14, and peaked 28 days post-vaccination. Specific T-cell response peaked at day 14 post-vaccination.The Ad5 vectored COVID-19 vaccine is tolerable and immunogenic at 28 days post-vaccination. Humoral responses against SARS-CoV-2 peaked at day 28 post-vaccination in healthy adults, and rapid specific T-cell responses were noted from day 14 post-vaccination. Our findings suggest that the Ad5 vectored COVID-19 vaccine warrants further investigation.National Key R&D Program of China, National Science and Technology Major Project, and CanSino Biologics.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ava的应助被sun采纳,获得10
4秒前
11秒前
动听一德完成签到,获得积分10
11秒前
领导范儿的应助被ClaraClark591采纳,获得30
14秒前
22秒前
24秒前
sun发布了新的文献求助10
27秒前
ClaraClark591发布了新的文献求助30
29秒前
威武的又琴完成签到,获得积分10
33秒前
闪闪小凡完成签到,获得积分10
38秒前
46秒前
369ninja发布了新的文献求助10
51秒前
Tashanzhishi完成签到,获得积分10
1分钟前
优美的烙完成签到,获得积分10
1分钟前
打打的应助被科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
科目三的应助被科研通管家采纳,获得10
1分钟前
奔跑的应助被科研通管家采纳,获得10
1分钟前
愉快的惋庭完成签到,获得积分10
1分钟前
等待剑完成签到,获得积分10
1分钟前
1分钟前
Maestro_S的应助被爱学习的doge采纳,获得10
1分钟前
1分钟前
2分钟前
孙老师完成签到 ,获得积分10
2分钟前
AiQi完成签到 ,获得积分10
2分钟前
sfwrbh完成签到,获得积分10
2分钟前
多情的中蓝完成签到,获得积分10
2分钟前
甜蜜语堂完成签到,获得积分10
2分钟前
李爱国的应助被科研通管家采纳,获得10
3分钟前
Maestro_S的应助被科研通管家采纳,获得10
3分钟前
大医仁心完成签到 ,获得积分0
3分钟前
Ali发布了新的文献求助10
3分钟前
淡然的易槐完成签到,获得积分10
3分钟前
清脆妙梦发布了新的文献求助40
3分钟前
丰富的藏鸟完成签到,获得积分10
3分钟前
4分钟前
漂亮秋荷完成签到,获得积分10
4分钟前
Xuezhuoxin完成签到,获得积分10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179956
求助须知:如何正确求助?哪些是违规求助? 9570170
关于积分的说明 21808444
捐赠科研通 7775818
什么是DOI,文献DOI怎么找? 3433251
关于科研通互助平台的介绍 2557352
邀请新用户注册赠送积分活动 2478958